Ian Shott is a serial life science entrepreneur with extensive experience in executive roles, including Executive Chairman and Non-Executive Director positions. They co-founded Shott Trinova in 2012 and transformed Arcinova into a successful contract development and manufacturing organization, which was sold to Quotient Sciences in 2021. Previously, they founded and led Excelsyn, which was sold for a significant return in 2010. Ian has held numerous senior leadership positions in multinational companies and has served on various advisory boards, contributing significantly to the industrial biotechnology sector and mentoring emerging entrepreneurs. They hold visiting Professorships at three prestigious universities and have received multiple honorary doctorates for their impact in the field.
This person is not in the org chart
This person is not in any teams
This person is not in any offices